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H
uman immunodeficiency virus (HIV) infection and chronic drug abuse both compromise nutritional status. For individu-
als with both disorders, the combined effects on wasting, the nutritional consequence that is most closely linked to mor-
tality, appear to be synergistic. Substance abuse clinicians can improve and extend patients’ lives by recommending healthy diets;
observing and assessing for food insecurity, nutritional deficits, signs of weight loss and wasting, body composition changes,
and metabolic abnormalities; and providing referrals to food programs and nutritionists. More studies are needed on the nutri-
tional consequences of using specific illicit drugs, the impact on health of specific micronutrient and metabolic deficiencies seen
in people with HIV, and the causes and clinical implications of body fat changes associated with HIV.
Nutrition Issues in Chronic Drug Users Living With HIV Infection
N
utritionalstatusstronglyinfluencesthewell-beingandsurvivalofindi-
vidualslivingwithhumanimmunodeficiencyvirus(HIV)infection,
whichcompromisesnutritionalstatusincomplexwaysthatmaypro-
duce malnutrition via multiple mechanisms (Mangili et al., 2006).The limited
dataavailableonthetopicindicatethatinjectiondrugusefurtherincreasesHIV-
infectedindividuals’nutritionalrisk(Forrester,Tucker,andGorbach,2004;Smit
et al., 1996):
•illicitdrugsmayinterferewithnutrientabsorptionoralterappetiteormetabolism;
•chronicdrugusers’lifestylesmaylowernutritionalstatusbyimpairingaccessto
food, food selection, housing, and social support (Kim et al., 2001; Smit et
al., 1996); and
• coinfection with hepatitis is common in injection drug users (IDUs) and has
thepotentialtoalternutritionalstatussignificantly(Pirothetal.,1998).Patients
withhepatitisfrequentlyloseweightandmaydevelopanemiaandneutropenia
(Soriano et al., 2002). As liver disease advances, alterations in metabolism
may lead to dietary intolerance or limit nutrient intake.
This article reviews nutritional issues affecting HIV-positive IDUs. Many of
the same issues likely also apply to HIV-infected chronic noninjecting users of
illicitdrugsandindividualsinearlyrecovery,whooftenconfrontlifestyle,social,
andeconomicissuessimilartothosethatcompromisethenutritionofIDUs.We
discuss the prevalence, causes, assessment of, and appropriate clinical responses
to wasting and weight loss, micronutrient deficiencies, and body fat redistribu-
tion and metabolic abnormalities.
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WASTING AND WEIGHT LOSS
Early in the HIV epidemic, researchers established an
independentlinkbetweenseveremalnutritionandmor-
talityamongHIV-infectedindividuals.Deathwasfound
to occur, on average, when body weight fell below 66
percent of the ideal body weight (IBW) or when lean
body mass (LBM) fell below 54 percent of the norm
(Kotleretal.,1989).Today,advancesinunderstanding
and treatment of HIV have markedly lowered the fre-
quencyofseveremalnutritioninpopulationswithaccess
to highly active antiretroviral therapy (HAART). For
example,datafromtheAdultandAdolescentHIVDis-
easeProjectindicatethattheincidenceofHIVwasting
syndrome, as defined by the Centers for Disease Con-
trolandPrevention(CDC),declinedfrom30.2to11.9
casesper1,000person-yearsofinfectionbetween1992
and 1999, with most of the drop occurring after the
introduction of HAART in late 1995 (Dworkin,
Williamson, and Adult/Adolescent Spectrum of HIV
DiseaseProject,2003).Thisprogressnotwithstanding,
unintentionalweightlossandwastingcontinuetocon-
tributetomorbidityandmortalityintheHIV-infected
population.Onestudyfoundthatadropof5to10per-
cent from the patient’s initial body weight quadrupled
his or her risk of death (Tang et al., 2002). Conversely,
inacohortofHIV-positivewomen,noneofwhomwere
on HAART at baseline and almost half of whom had a
historyofinjectiondruguse,ahigherbodymassindex
(BMI) and increases in BMI were associated with a
decreasedriskofdiseaseprogression(Jonesetal.,2003).
Themostwidelyusedstandardforidentifyingindi-
vidualswithHIVwhoseconditionwarrantsnutritional
ormedicalinterventiontoincreaseweightorbodymass
is the CDC AIDS surveillance case definition for
wasting:profoundinvoluntaryweightlossofmorethan
10 percent of baseline body weight plus either chronic
diarrhea (at least two loose stools per day for 30 days
or more) or chronic weakness and documented fever
(constant or intermittent for 30 days or more) in the
absence of a concurrent illness or other condition that
might cause such symptoms (e.g., cancer, tuberculosis,
cryptosporidiosis, or other specific enteritis) (Centers
for Disease Control and Prevention, 1987).
ADepartmentofHealthandHumanServicesWork-
ing Group has suggested expanding the diagnosis of
wastingtoalsoincludepatientswhoweighlessthan90
percent of their IBW (or have a BMI less than 18.5),
havelostmorethan10percentoftheirpre-illnessmax-
imum weight, or have experienced weight loss of more
than 5 percent in the previous 6 months (Grinspoon,
Mulligan,andDepartmentofHealthandHumanServ-
ices Working Group on the Prevention andTreatment
ofWastingandWeightLoss,2003).Theaimofthepro-
posedchangesistoidentifyat-riskpatientssooner,espe-
cially in light of evidence that HAART has altered the
characteristics of wasting in ways that render the CDC
definition a less sensitive predictor of nutritional risk.
For example, the Multicenter AIDS Cohort Study of
5,622 men in Baltimore, Chicago, Los Angeles, and
Pittsburghfoundthatpatientsreporteddiarrheaasfre-
quently in the HAART era as before, but experienced
lessanemia,fever,fatigue,andthrush(Smitetal.,2002).
Usingthreeofthenewlyproposedcriteria—weightless
than 90 percent of IBW, or a BMI less than 18.5, and
weight loss of more than 10 percent—Campa and col-
leagues(2005)foundan18percentprevalenceofwast-
ing among 119 HIV-infected IDUs.
Reviews of wasting and malnutrition in HIV-posi-
tiveIDUsindicatethatthecausesaremultifactorialand
may be secondary to decreased dietary intake, malab-
sorption, or increased resting energy expenditure (see
EtiologyofWastingandWeightLossinHIV-InfectedInjec-
tion Drug Users) (Mangili et al., 2006; Smit andTang,
2000). Injection drug use promotes each of these fac-
tors independently of HIV. In one study among His-
panicHIV-negativewomen,IDUsreportedmorefood
insecurity, fewer meals per week, lower intake of veg-
etablesandfish,andmoreingestionofsweetsandfried
foodsthannon-IDUsfromthesamerelativelylowsocioe-
conomic stratum (Himmelgreen et al., 1998) (Figure
1).The IDUs registered lower scores in all anthropo-
metric measures except height.
The combined impact of HIV and injection drug
ETIOLOGY OF WASTING AND WEIGHT LOSS IN HIV-
INFECTED INJECTION DRUG USERS
Decreased dietary intake related to abdominal pain, anorexia, chaotic
lifestyle, dementia, depression, diarrhea, esophagitis, fatigue, food inse-
curity, mouth sores, nausea, and vomiting.
Malabsorption related to antibiotic-induced alterations in intestinal flora,
enteropathy, HIV-induced mucosal changes, Kaposi’s sarcoma, medica-
tion effects on absorption of specific nutrients, and opportunistic gas-
trointestinal infections.
Altered metabolism related to drug effects (e.g.,from cocaine), fever or
cytokine-induced increase in basal metabolic rate, hormonal deficiencies,
increased lean body mass breakdown, and medication (HAART) effects
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useonweightlossandwastingappearssynergistic.The
inadequatenutrientintakeassociatedwithchronicdrug
use leads to decreased nutritional status and impaired
immunity. In turn, weakened immunity allows viral
loads to increase, leading to more frequent secondary
infections. New infections increase nutritional needs,
further widening the gap between nutritional require-
mentsandattainment.SeveralstudiessuggestthatHIV
andinjectiondrugusetogetherexertamoredeleterious
effect on weight and body mass than either alone:
• Smit and colleagues (1996) surveyed 107 IDUs and
foundthatthosewhowereHIV-positivehadahigher
prevalenceofinvoluntaryweightlossthanthosewho
were HIV-negative, even though their self-reported
intakesofmacro-andmicronutrientsandcalorieswere
higher and exceeded estimated needs.
• StudiesofHispanicsintheBienestarcohort(n=285)
disclosed that HIV-positive IDUs had lower BMIs
than HIV-positive non-IDUs (Forrester, Tucker,
and Gorbach, 2004, 2005). Use of cocaine and con-
current use of cocaine and opiates were both associ-
ated with weight loss over time, while use of other
illicitdrugswasassociatedwithweightstability.Infec-
tionwithHIVorhepatitis,intestinalmalabsorption,
restingenergyexpenditure,dietandphysicalactivity,
asmeasuredinthesestudies,didnotexplaintheobserved
differencesinweightandBMI.Studiesareneededto
evaluatemorepreciselyhowdifferentillicitdrugsaffect
metabolism and whether they have a role in wasting.
• AstudyusingdatafromtheNutritionforHealthyLiv-
ing(NFHL)cohortfoundthatinjectiondrugusepre-
dicted lower BMI and fat mass among HIV-positive
women, but not men (Forrester et al., 2000). Both
maleandfemaleIDUsinthisstudyreportedadequate
dietaryenergyintake,onaverage,althoughmaleIDUs’
intakes of iron and zinc were significantly lower
than those of male non-IDUs.
Several other reports from the NFHL cohort shed
additional light on HIV-positive IDUs’ diets. Woods
andcolleagues(2002)linkedinjectiondrugusetogreater
dietaryvulnerabilityamongHIV-positivewomeninthe
sample; overall, 25 to 35 percent of infected women,
half of whom were drug users, reported intakes below
75 percent of the recommended dietary allowance for
keymicronutrients.Woodsalsofoundthatdietaryintake
increasedasweightandCD4cellcountdecreased,per-
hapsbecauseindividualsneededmorenutrientstomain-
tain weight as their disease progressed. Another analy-
sis (Kim et al., 2001) revealed that 36 percent of the
NFHL cohort met formal assessment criteria for food
insecurityasdefinedbyRadimer,Olson,andCampbell
(1990; see U.S.D.A. Food Security Survey) and that an
additional8percentdescribedthemselvesaspersistently
hungry.IDUsconsumedlessenergythannonusers,and
dietary inadequacy correlated with lifestyle and behav-
ioralfactors(Kimetal.,2001).Minorities,subjectswith-
outanadultcaregiver,subjectswithdependentchildren,
andthosewithoutfoodshoppingassistancehadlessade-
quate diets.
Data from other studies also indicate that lifestyle
and socioeconomic issues contribute to the nutritional
vulnerability of IDUs with HIV. Food insecurity and
viral load were independent predictors of wasting in
HIV-positiveIDUsinastudythatalsoidentifiedheavy
alcohol consumption, heavy cocaine use, and inability
to hold a job as contributors to the syndrome (Campa
etal.,2005).HIVinfectionalsohasbeenindependently
associatedwithfoodinsecurity;inaCanadianstudy,the
problemwasfivetimesasprevalentamongHIV-positive
individuals as in the general population (Normén et
al.,2005).Theimpactoflifestyleandsocioeconomicfac-
torsonHIV-relatedcare,includingadherencetoHAART,
is likely important but has not been well studied.
MICRONUTRIENT STATUS
ResearchershavetiedindividualmicronutrientstoHIV-
associatedoutcomessincethebeginningoftheepidemic.
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FIGURE 1. Injection Drug Use and Levels of Food Insecurity
All 32 low-income, injection drug-using (IDU) women in a survey indicated that they
sometimes could not obtain enough food to allay hunger and maintain adequate nutri-
tion. Nearly half indicated that they had experienced the most severe level of food inse-
curity, in which parents’ dietary sacrifices still do not leave enough food to fill their chil-
dren’s stomachs. Food insecurity was common but not universal and was less severe
among a comparison group of 41 low-income non-IDU women. (Himmelgreen et al.,
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U.S.D.A. FOOD SECURITY SURVEY
A questionnaire developed by U.S. Department of Agriculture
researchers assesses levels of food security. The questioner begins by
saying, “I’m going to start by reading you statements people have made
about their food situation and ask you whether they were true for you dur-
ing the past 12 months.”
1. “The food that I bought just didn’t last, and I didn’t have money to get
more.” During the last 12 months, was this true for you often, some-
times, or never?
2. “I couldn’t afford to eat balanced meals.” During the last 12 months,
was this true for you often, sometimes, or never?
3. In the last 12 months, did you or other adults in your household ever
cut the size of your meals or skip meals because there wasn’t enough
money for food?
4. If so, did this happen once or twice, in more than a couple of some
months but not all, or in almost every one of the last 12 months?
5. In the last 12 months, did you ever eat less than you felt you should
because there wasn’t enough money for food? Yes or no?
6. In the last 12 months, were you ever hungry but didn’t eat because
there wasn’t enough money for food? Yes or no?
For complete survey materials, with instructions for scoring, see:
www.ers.usda.gov/Briefing/FoodSecurity/surveytools/short2008.pdf. While
this survey was developed for research, providers may find the questions
useful in clinical settings and may consider recommending food assis-
tance programs to clients with survey scores corresponding to low or
very low food security.
Low levels of vitamins A and B12, zinc, and selenium
acceleratediseaseprogression(Baum,2000).Individu-
als with HIV generally have low levels of many other
micronutrients as well. However, the implications of
those deficits remain unclear, as their relationships to
outcomesareconfoundedbyvariationsindiseasesever-
ity,chronicinflammation,andtreatmentregimens(Tang
et al., 2005).
IDUs in one study reported adequate mean dietary
intakeofmicronutrients,butasignificantpercentageof
those who were HIV-positive were taking in less than
the recommended amounts of selenium, retinol, and
vitamin E (Forrester,Tucker, and Gorbach, 2004). In
other studies, researchers have documented low serum
micronutrient levels in IDUs, regardless of their HIV
status(NazrulIslam,JahangirHossian,andAshan,2001).
For example, injection drug use increases the risk for
irondeficiencyandirondeficiencyanemiainbothHIV-
positive and HIV-negative women (Dancheck et al.,
2005).HAARTtherapycanalleviateorresolveanemia,
which is a risk factor for shortened survival in HIV-
infected women (Berhane et al., 2004).
The majority of clinical trials assessing the impact
of micronutrient supplementation on HIV-associated
outcomes in developed countries have been small and
haveshownmodesteffects;theresults,takencollectively,
aremixed(Tangetal.,2005).Interestingly,arecentstudy
found that elevating the serum selenium level through
micronutrient supplementation increased CD4 cell
counts and reduced viral load in HIV-infected IDUs
(Hurwitz et al., 2007). Participants whose serum sele-
niumleveldidnotincreasedespitesupplementation—
because of either noncompliance with the regimen or
individualdifferencesinresponsetosupplementation—
gained no benefit compared with the placebo group.
These results underscore the need for individual nutri-
tional assessment to determine the necessity of and
response to micronutrient supplementation.
Ideally, people should strive to achieve an adequate
micronutrient intake by consuming a balanced diet of
varied,high-qualityfoods,ratherthanbyrelyingonsup-
plementation. Many questions remain with regard to
micronutrients and their role in HIV-associated out-
comes, including the potential impact of coinfections
and oxidative stress. HIV infection increases oxidative
stress—a buildup of potentially toxic oxygen-contain-
ing molecules—as indicated by increased plasma lev-
elsoflipidperoxidationand/orreducedantioxidantlev-
elscomparedwiththoseofhealthycontrols(Tangetal.,
2005). HIV-positive IDUs, with their combination of
dietaryandmetabolicriskformicronutrientdeficiency,
should be the focal population in research to answer
these questions.
FAT REDISTRIBUTION AND METABOLIC
COMPLICATIONS
Changes in body fat distribution are a common com-
plication of HIV infection (Wohl et al., 2006). Called
HIV-associatedlipodystrophysyndrome(HALS),these
changesmaybeperipheral(affectingthearms,legs,but-
tocks,andface)orcentral(affectingtheabdomen,chest,
and upper back) and may involve either lipoatrophy
(fat loss) or lipohypertrophy (fat gain; Figure 2).
The Fat Redistribution and Metabolic Change in
HIV Infection (FRAM) study systematically evaluated
fatlossandaccumulation(Bacchettietal.,2005;Study
ofFRAM,2006).Peripherallipoatrophyemergedasthe
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typicallyassociatedwithareciprocalincreaseinvisceral
adiposetissueortrunkfat.ForresterandGorbach(2003)
found,similarly,thatHIV-positivesubjectsonHAART,
bothIDUsandnon-IDUs,hadlessfatintheirarmsand
legsthansubjectswhowereeitherHIV-negativeornot
on HAART. In a comparison between HIV-positive
(n = 213) and HIV-negative (n = 100) IDUs, the pic-
turewasnotasclear(Smitetal.,2005).Fatlosswasmore
common among the infected group and was not asso-
ciated with HAART use. Central adiposity was more
commonamongIDUswhohadnotinjecteddrugsdur-
ing the previous 6 months, who were HIV-positive as
opposedtoseronegative,orwhowerereceivingHAART
as opposed to not receiving this therapy.These investi-
gators found that IDUs’ reports of body changes were
reasonably valid. HALS appears to be a dynamic syn-
drome, with patients developing and losing features of
fat loss and accumulation (Jacobson et al., 2005).The
syndromecontinuestobeasubjectofintenseresearch.
No therapy has been found to reverse lipoatrophy
completely(Wohletal.,2006).Althoughchangingthe
HAART regimen or stopping protease inhibitor ther-
apy has been shown to improve some of the metabolic
abnormalitiesseeninHIVinfection,ithasnotimproved
lipoatrophy. Relatively little is known about the influ-
enceofdietonthedevelopmentofHIV-associatedlipo-
atrophy,andmoreresearchisneededtodeterminespe-
cificguidelinesforclinicallyefficaciousnutritiontherapy
(Dong and Hendricks, 2005). Studies to date indicate
that patients may decrease their risk of some forms of
fatdepositionbymaintaininghigh-fiberandhealthyfat
intakes (Hadigan et al., 2001; Hendricks et al., 2003)
and,moregenerally,byfollowingthesamedietaryguide-
lines that decrease chronic disease risk in the general
population (Dong and Hendricks, 2005).
HIVinfectionandsomeHIVmedicationsincrease
theriskofdyslipidemiaandalteredglucosemetabolism.
The lipid abnormalities seen most commonly in HIV-
infectedindividualsincludereducedhigh-densitylipopro-
tein(HDL)levelsandincreasedtriglyceridelevels(Wanke
et al., 2002).Theoretically, the risk for cardiovascular
diseasethatisnormallyassociatedwiththesefactorsmay
be exacerbated in a state of chronic inflammation such
as that caused by HIV infection; as a result, lifestyle
HALS affects the distribution of fat throughout the body. These images of HIV-positive men show typical manifestations of the syn-
drome, such as lipoatrophy or fat loss in the face and arms (A and B), lipohypertrophy or fat deposition in the legs and abdomen (C and
D), a hypertrophied dorsocervical fat pad (E), and gynecomastia or fat gain in the fatty tissue of the chest (F). Studies suggest that a
high-fiber diet and healthy fat intake may forestall or alleviate HALS.
Panel A courtesy of AIDS Images Library, www.aidsimages.ch; panels B-F © 2008 Mediscan.
D E F
FIGURE 2. HIV-Associated Lipodystrophy Syndrome (HALS)
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changessuchasdietandsmokingcessationmaybepar-
ticularlyimportantinthispopulation(Dubéetal.,2003).
The alterations in glucose metabolism associated with
HIV and HAART include hyperglycemia and insulin
resistance (Wanke et al., 2002). Along with the virus
andmedications,additionalfactorssuchasgender,age,
BMI, diet, and levels of physical activity affect these
abnormalities(Wankeetal.,2002).Pendingstudiesthat
focusspecificallyonHIV-infectedIDUs,thesameinter-
ventions used to control these problems in the overall
population of HIV-infected individuals are warranted.
The advances in understanding and treatment that
havemadeHIVinfectionachronicmanageabledisease
have moved diet and other lifestyle risk factors for-
wardinresearchandclinicalimportance.Nutritionissues
related to aging—which include changes in taste and
appetite, decreased ability to perform activities of
daily living such as shopping for and preparing food,
andtheimpactofothermedicationsonnutritionalsta-
tus—also are of increasing concern as more people live
longer with HIV.
ASSESSMENT AND INTERVENTION
Common Nutrition Disorders in HIV-Infected Injection
DrugUsersliststhenutritionissuesseenmostfrequently
in HIV-infected IDUs. For the substance abuse clini-
cian, the best way to assess potential wasting may be to
observeorinquireaboutweightchangesandtoasksim-
plequestionsaboutthepatient’saccesstoadequatefood.
FoodsecurityisroutinelymonitoredintheUnitedStates
with household or individual surveys developed by the
U.S. Department of Agriculture (USDA); the six-item
Short Module, which may be useful for screening,
maybefoundatwww.ers.usda.gov/Briefing/FoodSecurity/
surveytools/short2008.pdf (see also U.S.D.A. Food Secu-
ritySurvey).Patientself-reportmaybethebestearlyindi-
catorofbodycompositionchanges;whensuchchanges
are noted or suspected, clinicians should use specific
body composition measures to assess body fat redistri-
bution.
Treatmentprovidersshouldtailornutritionrecom-
mendations to each patient’s social and medical needs.
Chronic drug users in treatment may be inpatients, in
whichcasemealsatthefacilityshouldbetheemphasis.
Foroutpatients,counselorsshouldhelpindividualsiden-
tify Federal nutrition program eligibility and educate
them about nutrition and food choices. Treatment
providers should counsel all HIV-positive IDUs, espe-
cially those with metabolic risk, to follow key recom-
mendations from the Dietary Guidelines for Americans
(U.S.DepartmentofHealthandHumanServices,2005),
which encourage the consumption of a nutrient-rich,
balanceddietthatisadequateinmicronutrients,appro-
priateexercise,andsmokingcessation(seeDietaryGuide-
linesforIDUswithHIV).Individualsvaryintheirnutri-
tional needs and their ability to make dietary changes.
Manywillbenefitfromreferraltoanutritionistforfur-
therhelpwithnutritioncounselingandfoodassistance.
Involuntaryweightlossisaseriousmedicalconcern,
andpatientsshouldbeinterviewedtodeterminepoten-
tialunderlyingcauses.Multipletherapiesexistforwast-
ing and weight loss; appropriate interventions for
individualpatientsdependontheetiologyoftheirweight
loss. In general, initial recommendations to reverse or
slow weight loss should promote greater calorie and
nutrient intake through increased consumption of a
nutrient-dense diet. Patients should be encouraged to
keep a simple food diary to share with their health care
provider, who can use it to identify reasons for weight
loss and ways to improve dietary intake. If weight loss
is not reversed, the patient requires referral to a nutri-
tionist for more in-depth dietary assistance. Although
the use of meal replacements and appetite stimulants
canbehelpfulinsomecases,theseinterventionsshould
besupervisedbyaclinicianornutritionistwhocaneval-
uate their impact on overall dietary intake, metabolic
risk factors, and nutritional efficacy.
CONCLUSION
Malnutrition,deficienciesofmicronutrients,andcom-
plications with metabolism and body composition are
COMMON NUTRITION DISORDERS IN
HIV-INFECTED INJECTION DRUG USERS
Wasting and Weight Loss
Micronutrient Deficiencies
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Retinol
Metabolic Abnormalities
Dyslipidemia
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Fat deposition
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common in HIV and often lead to lowered immunity
and reduce the chance of survival. Drug use compli-
cates these issues and increases the likelihood of food
insecurity and wasting. When treating patients with
HIV who are chronic drug users or in recovery, clini-
cians must pay particular attention to nutrition status
aswellaslifestyleandsocioeconomicproblemsthatmay
compromise individuals’ access to food and dietary
intake.Basicassessmentsfornutritionaldeficitsinclude
globalobservation;patientself-reportsofweightchanges,
foodavailability,andfoodintake;calculationsofBMI;
and estimated nutrient needs. To prevent or reverse
nutritional deficits, clinicians and counselors can pro-
motenormalhealthydiets;directpatientstofoodassis-
tance programs; refer patients to nutritionists; or pre-
scribe meal replacements and dietary supplements.
Researchisneededtobetterunderstandthenutritional
consequences of illicit drug use, the impact of specific
micronutrientandmetabolicdeficiencies,andthecauses
and implications of HALS.
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DIETARY GUIDELINES FOR IDUs WITH HIV
Basic healthy eating guidelines for IDUs with HIV do not differ from those for
the general public, given below. Those individuals who cannot maintain
healthy weight or who develop malabsorption or metabolic alterations may
require specialist nutritional attention and clinical intervention.
Balance energy consumption and expenditure to achieve a healthy
weight.
Eat a balanced diet and engage in regular physical activity.
Consume a diet rich in a variety of fruits and vegetables.
Consume whole grains and high-fiber foods often.
Keep total fat consumption between 20 and 35 percent of calories and
saturated fat to less than 10 percent, with most fats coming from fish,
nuts, and vegetable oils.
Limit salt consumption.
If you drink alcohol, do so in moderation.
Remember that food safety is important; clean, cook, and store food
appropriately.
Sources: www.health.gov/dietaryguidelines and www.americanheart.org.
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